Using animal models to develop new treatments for tuberculosis

Research output: Contribution to journalArticle

Abstract

Animal models have an important role in the preclinical evaluation of new antituberculosis drug candidates. Although it does not recapitulate the clinicopathological manifestations of tuberculosis in humans, the mouse remains the best characterized and most economical animal model for experimental chemotherapy. Provided care is taken to optimize the experimental conditions, the mouse has produced reliable data on the bactericidal and sterilizing activity of existing antituberculosis drugs and informed numerous clinical trials. Still, other animal models, especially the guinea pig, may have utility as confirmatory, or even alternative, models under certain circumstances. This chapter reviews some of the important considerations when selecting an animal model and presents a model for the sequential evaluation of a new compound with promising antituberculosis activity.

Original languageEnglish (US)
Pages (from-to)542-551
Number of pages10
JournalSeminars in Respiratory and Critical Care Medicine
Volume29
Issue number5
DOIs
StatePublished - Oct 2008

Fingerprint

Tuberculosis
Animal Models
Therapeutics
Pharmaceutical Preparations
Guinea Pigs
Clinical Trials
Drug Therapy

Keywords

  • Animal models
  • Latent tuberculosis infection
  • Treatment
  • Tuberculosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Using animal models to develop new treatments for tuberculosis. / Nuermberger, Eric.

In: Seminars in Respiratory and Critical Care Medicine, Vol. 29, No. 5, 10.2008, p. 542-551.

Research output: Contribution to journalArticle

@article{6fd0b88e431e4aacb80c6b3b61bb6cd8,
title = "Using animal models to develop new treatments for tuberculosis",
abstract = "Animal models have an important role in the preclinical evaluation of new antituberculosis drug candidates. Although it does not recapitulate the clinicopathological manifestations of tuberculosis in humans, the mouse remains the best characterized and most economical animal model for experimental chemotherapy. Provided care is taken to optimize the experimental conditions, the mouse has produced reliable data on the bactericidal and sterilizing activity of existing antituberculosis drugs and informed numerous clinical trials. Still, other animal models, especially the guinea pig, may have utility as confirmatory, or even alternative, models under certain circumstances. This chapter reviews some of the important considerations when selecting an animal model and presents a model for the sequential evaluation of a new compound with promising antituberculosis activity.",
keywords = "Animal models, Latent tuberculosis infection, Treatment, Tuberculosis",
author = "Eric Nuermberger",
year = "2008",
month = "10",
doi = "10.1055/s-0028-1085705",
language = "English (US)",
volume = "29",
pages = "542--551",
journal = "Seminars in Respiratory and Critical Care Medicine",
issn = "1069-3424",
publisher = "Thieme Medical Publishers",
number = "5",

}

TY - JOUR

T1 - Using animal models to develop new treatments for tuberculosis

AU - Nuermberger, Eric

PY - 2008/10

Y1 - 2008/10

N2 - Animal models have an important role in the preclinical evaluation of new antituberculosis drug candidates. Although it does not recapitulate the clinicopathological manifestations of tuberculosis in humans, the mouse remains the best characterized and most economical animal model for experimental chemotherapy. Provided care is taken to optimize the experimental conditions, the mouse has produced reliable data on the bactericidal and sterilizing activity of existing antituberculosis drugs and informed numerous clinical trials. Still, other animal models, especially the guinea pig, may have utility as confirmatory, or even alternative, models under certain circumstances. This chapter reviews some of the important considerations when selecting an animal model and presents a model for the sequential evaluation of a new compound with promising antituberculosis activity.

AB - Animal models have an important role in the preclinical evaluation of new antituberculosis drug candidates. Although it does not recapitulate the clinicopathological manifestations of tuberculosis in humans, the mouse remains the best characterized and most economical animal model for experimental chemotherapy. Provided care is taken to optimize the experimental conditions, the mouse has produced reliable data on the bactericidal and sterilizing activity of existing antituberculosis drugs and informed numerous clinical trials. Still, other animal models, especially the guinea pig, may have utility as confirmatory, or even alternative, models under certain circumstances. This chapter reviews some of the important considerations when selecting an animal model and presents a model for the sequential evaluation of a new compound with promising antituberculosis activity.

KW - Animal models

KW - Latent tuberculosis infection

KW - Treatment

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=53549104456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53549104456&partnerID=8YFLogxK

U2 - 10.1055/s-0028-1085705

DO - 10.1055/s-0028-1085705

M3 - Article

VL - 29

SP - 542

EP - 551

JO - Seminars in Respiratory and Critical Care Medicine

JF - Seminars in Respiratory and Critical Care Medicine

SN - 1069-3424

IS - 5

ER -